EGFR and breast carcinoma: For instance, EGFR is known to form complexes with PGRMC1, in a PGRMC1 dimer-dependent manner [8,33] and both experimental strategies (siRNA and AG-205) led to reduced EGFR levels in breast cancer cells [8].